When Can Biochemical Recurrence Be Considered A Surrogate For Harder Clinical Endpoints In High Risk Prostate Cancer Patients Treated With Radical Prostatectomy? Results From A Large, Multi-Institutional, Long-Term AnalysesEmanuele Zaffuto,Marco Bianchi,Giorgio Gandaglia,Nicola Fossati,Paolo Dell'Oglio,Lorenzo Tosco,Paolo Gontero,R. Jeffrey Karnes,Piotr Chlosta,Felix K. H. Chun,Christian Gratzke,Markus Graefen,Derya Tilki,Burkhard Kneitz,Giansilvio Marchioro,Rafael Sanchez-Salas,Bertrand Tombal,Henk Van Der Poel,Jochen Walz,Pierre I. Karakiewicz,Hein Van Poppel,Martin Spahn,Francesco Montorsi,Alberto BrigantiThe Journal of Urology(2018)引用 0|浏览24暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要